Additional file 1 of Clinical and economic impact of ���ROS1-testing��� strategy compared to a ���no-ROS1-testing��� strategy in advanced NSCLC in Spain

Autor: Rojo, Federico, Conde, Esther, Torres, H��ctor, Cabez��n-Guti��rrez, Luis, Bautista, Dolores, Ramos, Inmaculada, Carcedo, David, Arrabal, Natalia, Garc��a, J. Francisco, Gal��n, Raquel, Nadal, Ernest
Rok vydání: 2022
DOI: 10.6084/m9.figshare.19386703.v1
Popis: Additional file 1: Table 1. Efficacy (median PFS and median OS) and costs associated with each first-line treatments.
Databáze: OpenAIRE